Correlation and expression of p53, HER-2, vascular endothelial growth factor (VEGF), and e-cadherin in a high-risk breast-cancer population
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Archived primary breast tumors from 77 patients were assessed by immunohistochemical analysis for expression of human epidermal growth receptor 2 (HER-2), p53, vascular endothelial growth factor (VEGF), and e-cadherin, and the relationships between the expressions of these molecules were studied.
Twenty-two (29%) patients had advanced (stage III or IV) disease. HER-2, VEGF, e-cadherin, and p53 signal were positive for 31 (40%), 58 (75%), 63 (82%), and 37 (48%) of patients, respectively. Among the markers tested, only p53 exhibited a significant association between expression and stage of the disease (P = 0.012). Expression of e-cadherin was positively associated with HER-2 overexpression (P = 0.004), and high levels of HER-2 occurred with strongly positive e-cadherin tumors. Marginally significant positive associations were observed between HER-2 and p53 signal (P = 0.06), and between disease stage and e-cadherin expression (P = 0.08).
The significant tendency toward expression of e-cadherin in conjunction with HER-2 overexpression in breast cancer is a novel finding. The association of p53 with more advanced stages of cancer emphasizes it as a key participant in metastatic processes in breast cancer.
- Correlation and expression of p53, HER-2, vascular endothelial growth factor (VEGF), and e-cadherin in a high-risk breast-cancer population
International Journal of Clinical Oncology
Volume 9, Issue 3 , pp 154-160
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Aggressive breast carcinoma
- Industry Sectors
- Author Affiliations
- A1. Avon Pathogenomics Laboratory at Winship Cancer Institute & Emory University School of Medicine, P.O. Box 55440, Atlanta, GA, 30308, USA
- A2. Department of Pathologyy, Grady Memorial Hospital & Emory University School of Medicine, Atlanta, GA, USA
- A3. Rollins School of Public Health at Emory University, Atlanta, GA, USA